PQJCX | VISGX | PQJCX / VISGX | |
Total Expense Ratio | 0.95 | 0.19 | 500% |
Annual Report Gross Expense Ratio | 2.31 | 0.19 | 1,216% |
Fund Existence | 9 years | 27 years | - |
Gain YTD | -2.172 | 4.368 | -50% |
Front Load | N/A | N/A | - |
Min. Initial Investment | 0 | 3000 | - |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 12.2M | 37.5B | 0% |
Annual Yield % from dividends | 0.27 | 0.42 | 64% |
Returns for 1 year | -4.66 | 11.37 | -41% |
Returns for 3 years | 17.46 | 33.17 | 53% |
Returns for 5 years | 9.85 | 35.14 | 28% |
Returns for 10 years | N/A | 135.94 | - |
1 Day | |||
---|---|---|---|
ETFs / NAME | Price $ | Chg $ | Chg % |
ZOCT | 26.35 | 0.06 | +0.24% |
Innovator Eq Dfnd Prt ETF - 1 Yr Oct | |||
APCB | 29.59 | N/A | -0.01% |
ActivePassive Core Bond ETF | |||
SPLG | 75.60 | -0.31 | -0.41% |
SPDR® Portfolio S&P 500® ETF | |||
GDXD | 1.90 | -0.01 | -0.52% |
MicroSectors™ Gold Mns 3X Inv Lvrgd ETN | |||
PBE | 67.58 | -1.26 | -1.83% |
Invesco Biotechnology & Genome ETF |